Recent results in JAMA (https://cutt.ly/RjIOIS9 & https://cutt.ly/njIOPM5) show that digital symptom monitoring during chemotherapy can help patients improve quality of life, live longer and reduce hospitalisation and ER visits. Therefore, it seems DTx in oncology has a great potential, yet to be explored. 

What impact might DTx solutions have on the quality of life? Can they address fatigue, nutrition, caregiver support and education? Are quality of life DTx solutions the ones with the greatest opportunity in oncology? Would the different stakeholders use these products? 

Although cancer is a source of significant and growing mortality worldwide, DTx within oncology is still at the beginning of the journey. Will this change?